SEC 13F Intelligence

Venrock Adviser, LLC / ABVX

Venrock Adviser, LLC’s Abivax SA Position

Does Venrock Adviser, LLC own Abivax SA (ABVX)? Not currently — the last reported position was 576.7K shares worth $49M in Q3 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$49M
Q3 2025
Shares
576.7K
% of Portfolio
+2.76%
Quarters Held
8
position exited

Position History ABVX

Reported value by quarter
Q4 ’23: $11MQ4 ’23Q1 ’24: $19MQ1 ’24Q2 ’24: $18MQ2 ’24Q3 ’24: $16MQ3 ’24Q4 ’24: $10MQ4 ’24Q1 ’25: $8MQ1 ’25Q2 ’25: $10MQ2 ’25Q3 ’25: $49MQ3 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2025576.7K$49M+2.76%
Q2 20251.35M$10M+0.77%
Q1 20251.35M$8M+0.72%
Q4 20241.35M$10M+0.68%
Q3 20241.35M$16M+0.81%
Q2 20241.35M$18M+1.13%
Q1 20241.35M$19M+0.92%
Q4 2023998.6K$11M+0.73%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Venrock Adviser, LLC’s full portfolio or all institutional holders of ABVX.